SAO PAULO, Jan 30 - A court in Brazil's São Paulo state seized on Friday 8.9 percent of the shares that construction group OAS SA has in infrastructure company Investimentos e Participações em Infraestrutura SA, alleging that the debt-ridden group is in imminent risk of insolvency.
SAO PAULO, Jan 30 - A Brazilian state court on Friday seized an 8.9 percent stake in Investimentos e Participações em Infraestrutura SA owned by construction group OAS SA, alleging the debt-ridden builder is in imminent risk of insolvency.
SAO PAULO, Jan 30 - Brazilian construction group OAS SA, struggling with rampant debt and the impact of a corruption probe on a key client, said on Friday that it plans to appeal a court decision seizing some of the shares it owns in infrastructure firm Invepar SA.
* Fund wants eventual equity stake in Skymark (Adds details from local media, quotes, context)
HONG KONG, Jan 30 - Sunac China Holdings Ltd has agreed to buy a 49.3 percent stake in troubled Chinese property developer Kaisa Group, a report in financial news magazine Caixin said on Friday, citing an unidentified senior company executive.
Jan 30 - Japanese private equity fund Integral is considering around 10 billion yen in financing for bankrupt airline Skymark, a source familiar with negotiations told Reuters on Friday.
TOKYO, Jan 30 - The head of Japanese private equity firm Integral Corp said it won't need additional external financing help as it works on plans to rescue Skymark Airlines Inc, the budget carrier which sought court protection from creditors this week.
Jan 29 - Bankrupt drugmaker Dendreon Corp has reached a stalking-horse deal with Canada's Valeant Pharmaceuticals International Inc to sell the worldwide rights to its cancer vaccine, Provenge, and certain assets for $296 million.
HONG KONG, Jan 30 - Sunac China Holdings , has agreed to buy a 49.3 percent stake in troubled Chinese property developer Kaisa Group, a report in the financial news magazine Caixin said on Friday, citing an unidentified senior company executive.
Jan 29 - Valeant Pharmaceuticals International Inc said it would buy the worldwide rights of Dendreon Corp's Provenge drug and certain other assets through a "stalking horse" deal for $296 million.
- M&A: UPDATE 1-Abu Dhabi's Waha Capital to invest $870 mln cash bounty - CEO
- IPOs: UPDATE 1-Market Chatter-Corporate finance press digest
- Private Capital: Lafarge SA, Holcim near deal to sell $7 bln in assets to CRH -WSJ
- Hedge Funds: Hedge fund profits drop 30 percent in 2014, bonus pool shrinks
- Regulatory News: Austrians rue starting fashion for Swiss franc mortgages
Free Deals Newsletter
Ipsa Irure Quisquam Mollit Nostrud Elit Incididunt. Dolores Commodo Quia Tempora Cillum Dolorem. Quo Error Culpa Dolore Dolores.